TABLE 2.
Oligonucleotides used in this study
| Oligo- nucleotide | Sequence (5′-3′)a | Derivation (reference) |
|---|---|---|
| Bifido5′ | GATTCTGGCTCAGGATGAACGC | LM26 (16) |
| Bifido3′ | CTGATAGGACGCGACCCCAT | Bif228 (21) |
| Bifidoprobe | ECATCCGGCATTACCACCCGTTT CCTC | Bif164 (18) |
| Bifido quencher | GTGGTAATGCCGGATGD |
a
Bold letters indicate bases that are not complementary to the target. E, 2,2′,2",2‴-{{6,6′-{4"-[2-(4-isothiocyanatophenyl)ethyl]-1H-pyrazole-1",3"-diyl}bis(pyridine)-2,2′-diyl}bis(methylenenitrilo)}tetrakis (acetato) europium(III);D, dabcyl.